ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 53 filers reported holding ADC THERAPEUTICS SA in Q1 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $160,584 | +10.3% | 74,690 | 0.0% | 0.00% | – |
| Q1 2023 | $145,646 | -49.2% | 74,690 | 0.0% | 0.00% | – |
| Q4 2022 | $286,810 | -21.4% | 74,690 | 0.0% | 0.00% | – |
| Q3 2022 | $365,000 | -50.3% | 74,690 | -19.1% | 0.00% | -100.0% |
| Q2 2022 | $734,000 | -45.9% | 92,290 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,356,000 | -27.3% | 92,290 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $1,864,000 | -25.6% | 92,290 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $2,507,000 | +41.4% | 92,290 | +9.5% | 0.00% | +50.0% |
| Q2 2021 | $1,773,000 | -13.8% | 84,290 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $2,058,000 | +22.5% | 84,290 | +60.6% | 0.00% | 0.0% |
| Q4 2020 | $1,680,000 | – | 52,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 5,402,041 | $4,845,631 | 1.54% |
| Sio Capital Management, LLC | 3,294,534 | $2,955,197 | 0.92% |
| Redmile Group, LLC | 14,178,045 | $12,717,706 | 0.60% |
| AlphaCentric Advisors LLC | 1,068,468 | $958,416 | 0.54% |
| Vantage Consulting Group Inc | 850,737 | $763,111 | 0.51% |
| Blue Owl Capital Holdings LP | 733,568 | $654,489 | 0.51% |
| Affinity Asset Advisors, LLC | 1,100,000 | $986,700 | 0.28% |
| Frazier Life Sciences Management, L.P. | 1,647,030 | $1,477,386 | 0.10% |
| Indie Asset Partners, LLC | 92,700 | $83,152 | 0.08% |
| GCM Grosvenor Holdings, LLC | 410,888 | $368,567 | 0.07% |